Rho 7 Activators are chemical compounds that indirectly enhance the functional activity of Rho 7, predominantly via the modulation of the Rho-associated protein kinase (ROCK) pathway. The Rho family of GTPases, which include well-studied members like Rho, Rac, and Cdc42, are involved in the regulation of a wide array of cellular functions, such as cytoskeletal dynamics, cell migration, cell cycle progression, and gene expression.
Activators within the Rho family typically work by promoting the GTP-bound active state of the protein. Direct activators would likely interact with the GTPase domain of the protein to either facilitate the displacement of GDP in favor of GTP binding or inhibit the intrinsic GTPase activity that leads to the hydrolysis of GTP, thereby maintaining the protein in an active state. This could be accomplished through stabilization of the GTP-bound conformation or by hindering the action of regulatory proteins such as GTPase-activating proteins (GAPs), which accelerate the hydrolysis of GTP. Indirect activators may exert their effects by modulating the expression levels of the Rho protein or its regulatory partners, such as guanine nucleotide exchange factors (GEFs), which promote the exchange of GDP for GTP, or by inhibiting GAPs. Additional indirect mechanisms might involve the alteration of post-translational modifications of the Rho protein, which can affect its membrane localization and interaction with other effector proteins, or by changing the lipid composition of cellular membranes, which can also influence Rho protein activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of the Rho-associated protein kinase (ROCK), which is downstream of Rho 7. By inhibiting ROCK, Y-27632 can reduce the inhibitory phosphorylation of downstream targets, indirectly enhancing Rho 7 activity and its associated cellular functions such as cytoskeleton organization. | ||||||
H-1152 dihydrochloride | 451462-58-1 | sc-203592 sc-203592A | 1 mg 5 mg | $104.00 $364.00 | 7 | |
H-1152P is another potent inhibitor of ROCK. It indirectly enhances Rho 7 activity by lowering the inhibitory phosphorylation of its downstream targets, leading to alterations in cellular processes like cell migration and morphology. | ||||||
Fasudil, Monohydrochloride Salt | 105628-07-7 | sc-203418 sc-203418A sc-203418B sc-203418C sc-203418D sc-203418E sc-203418F | 10 mg 50 mg 250 mg 1 g 2 g 5 g 10 g | $18.00 $33.00 $87.00 $168.00 $253.00 $496.00 $910.00 | 5 | |
Fasudil is a potent ROCK inhibitor. By preventing ROCK's inhibitory actions on downstream targets, Fasudil indirectly enhances Rho 7 activity, leading to modifications in cell adhesion and motility. | ||||||
GSK 429286 | 864082-47-3 | sc-361200 sc-361200B sc-361200A | 1 mg 5 mg 10 mg | $40.00 $125.00 $235.00 | ||
GSK 429286A is a selective ROCK inhibitor. It indirectly enhances Rho 7 activity by reducing the inhibitory phosphorylation of downstream targets, impacting cellular processes like cell migration and morphology. | ||||||
RKI-1447 | 1342278-01-6 | sc-472590 | 1 mg | $330.00 | ||
RKI-1447 is a potent inhibitor of ROCK. It indirectly enhances Rho 7 activity by reducing the inhibitory phosphorylation of downstream targets, affecting cellular processes such as cytoskeleton organization. | ||||||
AZD1152-HQPA | 722544-51-6 | sc-265334 | 10 mg | $375.00 | ||
AZD 1152-HQPA is a selective inhibitor of Aurora B kinase, a downstream effector of ROCK. By inhibiting Aurora B kinase, it indirectly enhances Rho 7 activity, affecting cellular processes such as cell division and proliferation. | ||||||